Announcements

“Phage Therapy Related Microbial Succession Associated with Successful Clinical Outcome for a Recurrent Urinary Tract Infection”
by Austen Terwilliger, Justin Clark, Maile Karris, Haroldo Hernandez-Santos, Sabrina Green, Saima Aslam and Anthony Maresso
Viruses 2021, 13(10), 2049; https://doi.org/10.3390/v13102049
Available online: https://www.mdpi.com/1999-4915/13/10/2049

“Bacteriophage Rescue Therapy of a Vancomycin-Resistant Enterococcus faecium Infection in a One-Year-Old Child following a Third Liver Transplantation”
by Kevin Paul, Maya Merabishvili, Ronen Hazan, Martin Christner, Uta Herden, Daniel Gelman, Leron Khalifa, Ortal Yerushalmy, Shunit Coppenhagen-Glazer, Theresa Harbauer et al.
Viruses 2021, 13(9), 1785; https://doi.org/10.3390/v13091785
Available online: https://www.mdpi.com/1999-4915/13/9/1785

“The Safety and Toxicity of Phage Therapy: A Review of Animal and Clinical Studies”
by Dan Liu, Jonas D. Van Belleghem, Christiaan R. de Vries, Elizabeth Burgener, Qingquan Chen, Robert Manasherob, Jenny R. Aronson, Derek F. Amanatullah, Pranita D. Tamma and Gina A. Suh
Viruses 2021, 13(7), 1268; https://doi.org/10.3390/v13071268
Available online: https://www.mdpi.com/1999-4915/13/7/1268

“A Case of Phage Therapy against Pandrug-Resistant Achromobacter xylosoxidans in a 12-Year-Old Lung-Transplanted Cystic Fibrosis Patient”
by David Lebeaux, Maia Merabishvili, Eric Caudron, Damien Lannoy, Leen Van Simaey, Hans Duyvejonck, Romain Guillemain, Caroline Thumerelle, Isabelle Podglajen, Fabrice Compain et al.
Viruses 2021, 13(1), 60; https://doi.org/10.3390/v13010060
Available online: https://www.mdpi.com/1999-4915/13/1/60

“A Design of Experiment Approach to Optimize Spray-Dried Powders Containing Pseudomonas aeruginosaPodoviridae and Myoviridae Bacteriophages”
by Emilie Tabare, Tea Glonti, Christel Cochez, Cyrille Ngassam, Jean-Paul Pirnay, Karim Amighi and Jonathan Goole
Viruses 2021, 13(10), 1926; https://doi.org/10.3390/v13101926
Available online: https://www.mdpi.com/1999-4915/13/10/1926

“Characterization of Anti-Bacterial Effect of the Two New Phages against Uropathogenic Escherichia coli”
by Lívia Slobodníková, Barbora Markusková, Michal Kajsík, Michal Andrezál, Marek Straka, Adriána Liptáková and Hana Drahovská
Viruses 2021, 13(7), 1348; https://doi.org/10.3390/v13071348
Available online: https://www.mdpi.com/1999-4915/13/7/1348

“Past and Future of Phage Therapy and Phage-Derived Proteins in Patients with Bone and Joint Infection”
by Tristan Ferry, Camille Kolenda, Thomas Briot, Aubin Souche, Sébastien Lustig, Jérôme Josse, Cécile Batailler, Fabrice Pirot, Mathieu Medina, Gilles Leboucher et al.
Viruses 2021, 13(12), 2414; https://doi.org/10.3390/v13122414
Available online: https://www.mdpi.com/1999-4915/13/12/2414

“Phage Therapy Experience at the Eliava Phage Therapy Center: Three Cases of Bacterial Persistence”
by Elisabed Zaldastanishvili, Lika Leshkasheli, Mariam Dadiani, Lia Nadareishvili, Lia Askilashvili, Nino Kvatadze, Marina Goderdzishvili, Mzia Kutateladze and Nana Balarjishvili
Viruses 2021, 13(10), 1901; https://doi.org/10.3390/v13101901
Available online: https://www.mdpi.com/1999-4915/13/10/1901

“A Case of In Situ Phage Therapy against Staphylococcus aureus in a Bone Allograft Polymicrobial Biofilm Infection: Outcomes and Phage-Antibiotic Interactions”
by Brieuc Van Nieuwenhuyse, Christine Galant, Bénédicte Brichard, Pierre-Louis Docquier, Sarah Djebara, Jean-Paul Pirnay, Dimitri Van der Linden, Maya Merabishvili and Olga Chatzis
Viruses 2021, 13(10), 1898; https://doi.org/10.3390/v13101898
Available online: https://www.mdpi.com/1999-4915/13/10/1898

“Bacteriophage Therapy for Difficult-to-Treat Infections: The Implementation of a Multidisciplinary Phage Task Force (The PHAGEFORCE Study Protocol)”
by Jolien Onsea, Saartje Uyttebroek, Baixing Chen, Jeroen Wagemans, Cédric Lood, Laura Van Gerven, Isabel Spriet, David Devolder, Yves Debaveye, Melissa Depypere et al.
Viruses 2021, 13(8), 1543; https://doi.org/10.3390/v13081543
Available online: https://www.mdpi.com/1999-4915/13/8/1543

The low coverage of testing and treatment is the most important gap to be addressed to achieve the global elimination goals of hepatitis B virus (HBV) by 2030. 

To commemorate the World Hepatitis Day 2023, MDPI is launching a special webinar to encourage researchers to come together, take action, and highlight how the exchange of findings facilitates efforts to raise awareness of hepatitis.

We are looking forward to seeing you at the MDPI World Hepatitis Day Webinar 2023. 

Conference secretariat: Ms. Shun Li
Date and time: 28 July 2023, 7:00 a.m. and 3:00 p.m., CEST

This is a free webinar. After registering, you will receive a confirmation email containing information on how to join the webinar. Registrations with academic institutional email addresses will be prioritized. 

Unable to attend? Register anyway and we will let you know when the recording is available to watch. 

Session 1:

Register for Session 1 for free!

Session 2:

Register for Session 2 for free! 

Relevant Special Issues:
Pathogens
"Research on Hepatitis B Virus: Past, Present, and Future"
Edited by: Hyung Joon Yim
Submission deadline: 31 August 2023 

JPM
"Novel Challenges and Therapeutic Options for Liver Diseases"
Edited by: Guido Gerken
Submission deadline: 30 September 2023 

Medicina
"Viral Hepatitis Research: Updates and Challenges"
Edited by: Endrit Shahini, Antonio Giovanni Solimando and Antonella Argentiero
Submission deadline: 15 October 2023 

Cells
"Non-alcoholic Steatohepatitis (NASH) and Liver Fibrosis: Molecular and Multicellular Control of Evolving Diseased States"
Edited by: Jérôme Eeckhoute
Submission deadline: 15 February 2024 

Diagnostics
"Diagnosis and Management of Liver Diseases—2nd Edition"
Edited by: Jeong-Ju Yoo
Submission deadline: 30 September 2023 

Vaccines
"Vaccination and Treatments against Viral Hepatitis: Achievements, Challenges and Perspectives"
Edited by: Bárbara Vieira Do Lago and Vinicius M. Mello
Submission deadline: 15 October 2023

With the first issue released in June 2023, five new MDPI journals disseminating multi-disciplinary science are due to launch, which will cover the subjects of medicine & pharmacology, biology and physical sciences.

The newly launched journals will be overseen by professional Editorial Board Members and Editors to ensure an accurate and rapid publication, rigorous peer review and broad visibility.

Please feel free to browse and discover more about the new journals below.

Journal	Founding Editor-in-Chief	Journal topics (selected)
	Prof. Dr. Jun Ma, Peking University, China| Editorial | view inaugural issue	growth and development; diet and nutrients; school health promotion policies and practices; child health and care; adolescent health and wellbeing | view journal scope | submit an article
	Prof. Dr. Bernd Rehm, Griffith University, Australia | Editorial | view inaugural issue	DNA and gene synthesis; synthetic transcription factors; protein engineering; viral engineering; metabolic engineering | view journal scope | submit an article
	Prof. Dr. Varsha Gandhi, University of Texas MD Anderson Cancer Center, USA | Editorial | view inaugural issue	lymphatics; cancers associated with lymphocytes and lymphoblasts; lymphatic tissues; lymphoma; lymphoid leukemia | view journal scope | submit an article
	Dr. Bradley Turner, University of Melbourne, Australia | Editorial | view inaugural issue	multiple sclerosis; amyotrophic lateral sclerosis; primary lateral sclerosis; atherosclerosis; systemic sclerosis | view journal scope | submit an article
	Prof. Dr. Clemens Burda, Case Western Reserve University, USA | Editorial | view inaugural issue	Gamma ray, X-ray, and UV–Vis spectroscopies; NIR/mid-infrared/Raman spectroscopy; microwave and THz spectroscopy; high-resolution gas-phase atomic, molecular, and cluster spectroscopy; MS, NMR, and EPR spectroscopy | view journal scope | submit an article

We wish to thank everyone who has supported the development of open access publishing. You are welcome to submit an application to the New Journal Committee (newjournal-committee@mdpi.com) if you would like to create more new journals.

We are pleased to inform you that the Viruses’ 2022 Impact Factor is 4.7. Viruses (ISSN: 1999-4915) now ranks Q2 (15 among 36 titles) in the “Virology” category. Our journal continues to build momentum in the virology community.

For more journal statistics, please visit https://www.mdpi.com/journal/viruses/stats.  

The Viruses Editorial Office would like to thank all authors, reviewers, and editors who have contributed to the journal.

The 2022 citation metrics have been released in the Journal Citation Reports (JCR), and we’re pleased to announce the following results for MDPI journals:

We are thrilled to announce that 90% of our ranked MDPI journals, specifically 86 out of 96 (captured in the table below), are performing above average in Q1 or Q2. This year, Clarivate has expanded its Impact Factor (IF) awards to include journals in the Emerging Sources Citation Index (ESCI) and the Arts and Humanities Citation Index (AHCI), providing greater transparency for the full set of journals indexed in the Web of Science Core Collection. As a result, 111 of MDPI journals have received their first IF in 2023, with 37 journals surpassing an IF of 3.0. In total, 208 MDPI journals have been honored with an IF.

Clarivate explains that by "expanding the coverage but holding to highly selective standards, the [Impact Factor] is now a reliable indicator of trustworthiness, as well as a measure of scholarly impact, at the journal level."

Please visit our blog post where we discuss the release of the latest citation metrics with our Indexing Manager, Dr. Constanze Schelhorn, to find out what's different this time around and how to make use of different metrics available.

Note: The Journal of Personalized Medicine's Impact Factor was omitted in the original release and will be assigned separately. Please find the data on the journal webpage in due course.

Source: 2022 Journal Impact Factors, Journal Citation Reports ^TM (Clarivate, 2023)

We are pleased to inform you that Viruses (ISSN: 1999-4915) has received an updated CiteScore of 7.1, an increase of 7.57% compared with the 2021 metric. The 2022 CiteScore™ was released recently, making an assessment of the scientific influence of journals in the 2019 to 2022 period.

Viruses CiteScore ranks as follows:

• Q1 (74 out of 304 journals) in the “Infectious Diseases” category;
• Q2 (29 out of 75 journals) in the “Virology” category.

For more journal statistics, please visit https://www.mdpi.com/journal/viruses/stats.

Excellent performance is inseparable from the support and dedication of all journal editors, reviewers, authors, and readers. We would like to take this opportunity to thank all of you who have contributed to the journal.

MDPI journals will be attending the 42nd annual meeting of the American Society for Virology as an exhibitor. This meeting will be held in Athens, Georgia, USA from 24 to 28 June 2023.

The American Society for Virology (ASV) is a wonderful community that brings together virologists from all areas of the field. As a result, the annual meetings are rich in diverse scientific offerings and they can be quite large (sometimes over 1600 attendees). This conference is hosted by the University of Georgia and held at the Classic Center; the scientific program will include symposia, concurrent workshops, poster sessions, exhibits, and special events. Professional development activities and social events will be interspersed throughout the meeting.

The following MDPI journals will be represented:

• Biomedicines;
• Life;
• Viruses;
• Cells;
• Vaccines;
• Veterinary Sciences;
• Microorganisms;
• CIMB;
• Pathogens;
• TropicalMed;
• Zoonotic Diseases;
• COVID.

If you are attending this conference, please feel free to start a conversation with us. Our delegates look forward to meeting you in person and answering any questions you may have. For more information about the conference and our booth, please visit: https://asv.org/asv2023/.

On 7 April 2023—World Health Day, the World Health Organization (WHO) will observe its 75th anniversary. In 1948, countries of the world came together and founded the WHO to promote health, keep the world safe, and serve the vulnerable, so that everyone, everywhere, can attain the highest level of health and well-being. The WHO’s 75th anniversary is an opportunity to look back at public health successes that have improved quality of life over the last seven decades. It is also an opportunity to motivate action to tackle the health challenges of today and tomorrow. In order to encourage everyone to understand health and pay attention to health, we have also curated a list of publications on topics related to universal health coverage, healthy diet, and mental health. We also want to remind everyone that all research published in MDPI journals is available in an open access format, allowing practitioners, policy makers, and people around the world to access the latest scientific knowledge to build upon and share. Although we still have a long way to go to achieve universal health, this day also provides an opportunity to celebrate the progress made and inspire further action toward a more just and equitable world. Join us on a journey at MDPI to achieve Health for All.

• The Antioxidant Potential of the Mediterranean Diet as a Predictor of Weight Loss after a Very Low-Calorie Ketogenic Diet (VLCKD) in Women with Overweight and Obesity

  Antioxidants 2023, 12(1), 18; https://doi.org/10.3390/antiox12010018

• Effectiveness of Non-Contact Dietary Coaching in Adults with Diabetes or Prediabetes Using a Continuous Glucose Monitoring Device: A Randomized Controlled Trial

  Healthcare 2023, 11(2), 252; https://doi.org/10.3390/healthcare11020252

• The Association between Advanced Liver Fibrosis and Mortality Is Modified by Dietary Quality among Korean Adults: Results from the Korea National Health and Nutrition Examination Survey with Mortality Data

  Nutrients 2023, 15(6), 1501; https://doi.org/10.3390/nu15061501

• Physical Exercise and Diet: Regulation of Gut Microbiota to Prevent and Treat Metabolic Disorders to Maintain Health

  Nutrients 2023, 15(6), 1539; https://doi.org/10.3390/nu15061539

• Modelling and Prediction of the Spread of COVID-19 in Cameroon and Assessing the Governmental Measures (March–September 2020)

  COVID 2021, 1(3), 622-644; https://doi.org/10.3390/covid1030052

• SARS-CoV-2 Infection in Health Care Workers of Trieste (North-Eastern Italy), 1 October 2020–7 February 2022: Occupational Risk and the Impact of the Omicron Variant

  Viruses 2022, 14(8), 1663; https://doi.org/10.3390/v14081663

• Vaccination Coverage during Childhood and Adolescence among Undergraduate Health Science Students in Greece

  Children 2022, 9(10), 1553; https://doi.org/10.3390/children9101553

• Determinants of Equity in Coverage of Measles-Containing Vaccines in Wales, UK, during the Elimination Era

  Vaccines 2023, 11(3), 680; https://doi.org/10.3390/vaccines11030680

• Sex Differences in Substance Use, Prevalence, Pharmacological Therapy, and Mental Health in Adolescents with Attention-Deficit/Hyperactivity Disorder (ADHD)

  Brain Sci. 2022, 12(5), 590; https://doi.org/10.3390/brainsci12050590

• Impact on Students of the Act–Belong–Commit Mentally Healthy Schools Framework

  Children 2023, 10(3), 548; https://doi.org/10.3390/children10030548

• Psychological Health and Drugs: Data-Driven Discovery of Causes, Treatments, Effects, and Abuses

  Toxics 2023, 11(3), 287; https://doi.org/10.3390/toxics11030287

• Characterizing Touch Discrimination Impairment from Pooled Stroke Samples Using the Tactile Discrimination Test: Updated Criteria for Interpretation and Brief Test Version for Use in Clinical Practice Settings

  Brain Sci. 2023, 13(4), 533; https://doi.org/10.3390/brainsci13040533

Conference: 8th European Congress of Virology 2023
Date: 4–7 May 2023
Location: Gdańsk, Poland

MDPI will be attending the 8th European Congress of Virology 2023 (ECV 2023) as an exhibitor, and we welcome researchers from different backgrounds to visit and share their latest ideas with us.

This conference is organized by the European Society for Virology. ECV 2023 will be a great opportunity for European virologists representing various fields of research to meet, present their results, and discuss all the developments in virology that have taken place during this unusual time. It will also be a great opportunity to meet friends, renew old acquaintances, and establish new collaborations. Although coronavirus studies will undoubtedly be one of the leading subjects at ECV 2023, it is important to have all research areas represented, including basic, clinical, veterinary, and plant virology. 

The following MDPI journals will be represented:

• Viruses;
• Microorganism;
• Vaccines;
• Pathogens;
• Biomedicines;
• Veterinary Science;
• Immuno;
• COVID.

If you are planning to attend this conference, please do not hesitate to start an online conversation with us. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit the following website: https://www.eusv-congress.eu/.